E-LIB Suche - Ergebnisse für: Gehrmann, U

1

P153 Artificial Intelligence to predict interleukin-23 sign..:

Qaiser, T ; Hamidinekoo, A ; Daniel, S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i458-i458 , 2024

Link: https://doi.org/10.1093/..

2

DOP06 Deep characterization of IL-23 pathway in different g..:

Cairns, J ; Monkley, S ; Tian, S...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i64-i67 , 2023

Link: https://doi.org/10.1093/..

3

P082 The CCR9/CCL25 axis is specific to the ileum and is co..:

Gehrmann, U ; Csomor, E ; Monkley, S...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i247-i247 , 2023

Link: https://doi.org/10.1093/..

4

P025 Colonic rather than ileal expression of ITGA4/ITGB7 co..:

Csomor, E ; Gehrmann, U ; Monkley, S...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i195-i196 , 2023

Link: https://doi.org/10.1093/..

5

P277 Predicting disease relevant features in Crohn's Diseas..:

Mokhtari, R ; Hamidinekoo, A ; Lewis, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i427-i428 , 2023

Link: https://doi.org/10.1093/..

6

P879 Clinical significance of plasma interleukin-22 as a bi..:

Cabrera-Moksnes, C ; Fernandez-Llaneza, D ; Neisen, J...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i996-i997 , 2023

Link: https://doi.org/10.1093/..

7

Unmet needs in the management of exacerbations of chronic o..:

Waeijen-Smit, K ; Houben-Wilke, S ; DiGiandomenico, A..
Waeijen-Smit , K , Houben-Wilke , S , DiGiandomenico , A , Gehrmann , U & Franssen , F M E 2021 , ' Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease ' , Internal and Emergency Medicine , vol. 16 , no. 3 , pp. 559-569 . https://doi.org/10.1007/s11739-020-02612-9. , 2021

Link: https://cris.maastrichtu..

8

Ein generalisiertes NNT für ordinale und stetige Zielgrößen..:

Gehrmann, U ; Timmesfeld, N
Brunner E, Munzel U. Nicht-parametrische Datenanalyse. 2. Auflage. Springer Spektrum; 2013.. , 2021

Link: https://doi.org/10.3205/..

9

"Linked Evidence" - Wann lassen sich aus der Verknüpfung de..:

Eikermann, M ; Biester, K ; Skipka, G...
Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88-94.. , 2009

Link: https://doi.org/10.3205/..

10

Berechnung von adjustierten NNEs und Risikodifferenzen unte..:

Gehrmann, U ; Bender, R ; Kuß, O.
Bender R, Kuss O, Hildebrandt M, Gehrmann U. Estimating adjusted NNT statistics in logistic regression analysis. Stat Med. 2007 (submitted for publication).. , 2007

Link: http://www.egms.de/en/me..

11

Überlebenszeitanalyse mit Hilfe generalisierter linearer un..:

Gehrmann, U
Brezger A, Kneib T, Lang S. BayesX Version 0.9 Documentation. München: Institut für Statistik der Ludwig-Maximilians-Universität, 2002.. , 2006

Link: http://www.egms.de/en/me..

12

Analysis of the time to sustained progression in Multiple S..:

Gehrmann, U ; Hellriegel, Barbara ; Neiss, Albrecht.
Series: Discussion Paper. , 2003

Link: http://hdl.handle.net/10..

13

Exosomes : immunomodulators in cancer and therapy:

Hiltbrunner, Stefanie
I. Gehrmann U, Hiltbrunner S, Georgoudaki AM, Karlsson MC, Näslund TI, Gabrielsson S. Synergistic induction of adaptive antitumour immunity by codelivery of antigen with α-galactosylceramide on exosomes. Cancer Research, 2013, Jul 1;73(13):3865-76 ::doi::10.1158/0008-5472.CAN-12-3918 ::pmid::23658368 ::isi::000321112700007. , 2016

Link: http://hdl.handle.net/10..

14